Literature DB >> 16231004

Effects of urea pretreatment on the binding properties of adenosine A1 receptors.

Lauren T May1, Patrick M Sexton, Arthur Christopoulos.   

Abstract

The effect of denaturation and/or extraction of nonintegral membrane proteins by 7 M urea on the binding of the antagonist [3H]cyclopentyl-1,3-dipropylxanthine 8 dipropyl-2,3 ([3H]DPCPX), and the agonists adenosine, (-)-N6-(2-phenylisopropyl)-adenosine (R-PIA) and N6-cyclohexyladenosine (CHA), was investigated at human A1 adenosine receptors stably expressed in CHO cells. Pretreatment with urea caused a 56% reduction in membrane proteins. Compared to controls, the use of adenosine deaminase (ADA), 100 microM 5'-guanylylimidodiphosphate (Gpp(NH)p) or urea each caused equivalent increases in specific [3H]DPCPX binding. Neither the binding kinetics nor the affinity of [3H]DPCPX were significantly different in urea-pretreated compared to ADA-pretreated membranes. At 25 degrees C in ADA-pretreated membranes, the competition isotherms for R-PIA and CHA were characterized by two affinity states. Gpp(NH)p (100 microM) reduced, but did not abolish, the value of the high-affinity dissociation constant. Similar results were obtained after treatment with urea for R-PIA, whereas the high-affinity state for CHA was abolished. At 37 degrees C, urea pretreatment, but not 100 microM Gpp(NH)p, abolished high-affinity agonist competition binding. There was no significant effect of any of the treatments on the low-affinity agonist binding state. In urea-pretreated membranes, exogenously added adenosine competed according to a simple mass-action model with a pK(L) of 5.66+/-0.05 (n=3). Compared to the more common approaches of ADA treatment and/or use of guanine nucleotides, our findings suggest that urea pretreatment represents an inexpensive and useful approach for investigating the binding properties of adenosine A1 ligands (including adenosine) to the G protein-uncoupled form of the receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231004      PMCID: PMC1751243          DOI: 10.1038/sj.bjp.0706419

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Selective inactivation of guanine-nucleotide-binding regulatory protein (G-protein) alpha and betagamma subunits by urea.

Authors:  W K Lim; R R Neubig
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain.

Authors:  Xinhui Li; Dawn Conklin; Weiya Ma; Xiaoying Zhu; James C Eisenach
Journal:  Pain       Date:  2002-05       Impact factor: 6.961

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors.

Authors:  C Elisabet Tranberg; Andrea Zickgraf; Brian N Giunta; Henning Luetjens; Heidi Figler; Lauren J Murphree; Ruediger Falke; Holger Fleischer; Joel Linden; Peter J Scammells; Ray A Olsson
Journal:  J Med Chem       Date:  2002-01-17       Impact factor: 7.446

6.  The A1 adenosine receptor. Solubilization and characterization of a guanine nucleotide-sensitive form of the receptor.

Authors:  G L Stiles
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

7.  Allosteric adenosine modulation to reduce allodynia.

Authors:  H L Pan; Z Xu; E Leung; J C Eisenach
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

8.  Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism.

Authors:  Xinhui Li; Dawn Conklin; Hui-Lin Pan; James C Eisenach
Journal:  J Pharmacol Exp Ther       Date:  2003-02-20       Impact factor: 4.030

9.  Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine.

Authors:  C Kollias-Baker; J Ruble; D Dennis; R F Bruns; J Linden; L Belardinelli
Journal:  Circ Res       Date:  1994-12       Impact factor: 17.367

10.  Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.

Authors:  Keith Finlayson; Takuya Maemoto; Steven P Butcher; John Sharkey; Henry J Olverman
Journal:  Acta Pharmacol Sin       Date:  2003-08       Impact factor: 6.150

View more
  6 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

2.  Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.

Authors:  Katie Leach; Richard E Loiacono; Christian C Felder; David L McKinzie; Adrian Mogg; David B Shaw; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropsychopharmacology       Date:  2009-11-25       Impact factor: 7.853

3.  Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity.

Authors:  Gregory D Stewart; Celine Valant; Simon J Dowell; Dalibor Mijaljica; Rodney J Devenish; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Pharmacol Exp Ther       Date:  2009-07-29       Impact factor: 4.030

4.  Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor.

Authors:  Chandramohan Natarajan; Aaron N Hata; Heidi E Hamm; Roy Zent; Richard M Breyer
Journal:  Mol Pharmacol       Date:  2012-10-18       Impact factor: 4.436

5.  Minute-scale persistence of a GPCR conformation state triggered by non-cognate G protein interactions primes signaling.

Authors:  Tejas M Gupte; Michael Ritt; Matthew Dysthe; Rabia U Malik; Sivaraj Sivaramakrishnan
Journal:  Nat Commun       Date:  2019-10-23       Impact factor: 14.919

Review 6.  Polyamine: A Potent Ameliorator for Plant Growth Response and Adaption to Abiotic Stresses Particularly the Ammonium Stress Antagonized by Urea.

Authors:  Song Sheng; Changzheng Wu; Yucheng Xiang; Wenxuan Pu; Shuhui Duan; Pingjun Huang; Xiaoyuan Cheng; Yuanyong Gong; Yilong Liang; Laihua Liu
Journal:  Front Plant Sci       Date:  2022-03-23       Impact factor: 5.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.